Moderna, Inc. reports $389 million revenue for quarter ended March 31, 2026, up 260.2%

ยท MRNA

Moderna, Inc. reported revenue of $389 million for the quarter ended March 31, 2026, an increase of 260.2% from the same quarter a year earlier ($108 million).

For the same period it posted a net loss of $1.34 billion, or $-3.40 per diluted share (-2.52 a year earlier).

That is a net margin of -345.2%.

On Sanad's AAOIFI Standard 21 screen, Moderna, Inc. is currently not compliant: interest-bearing debt is 0.7% of market capitalisation (limit 30%), and impure income is 16.2% of revenue (limit 5%).

Source: 10-Q filed with the U.S. Securities and Exchange Commission on May 1, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.

More Moderna, Inc. news